Publication | Open Access

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors

Endocrine OncologyMedicineGynecologyPhase Ii StudyOvarian HormoneOncologyRadiation OncologyGynecology OncologyEndocrine-related CancerOvarian Cancer